Are Headaches Before Your Period Normal with Endometriosis?

Are Headaches Before Your Period Normal with Endometriosis?

Yes — premenstrual headaches are significantly more common in endometriosis than in the general population, but "normal" doesn't mean inevitable. The main driver is a sharp late-luteal drop in estrogen that, in endometriosis, is compounded by elevated prostaglandins and systemic inflammation. Women with comorbid migraine disorder or iron deficiency (common after heavy menstrual bleeding) are at the highest risk.

Why Endometriosis Makes Premenstrual Headaches More Likely

Endometriosis is not simply a pelvic condition. It is a systemic inflammatory disease in which endometrial-like tissue implants outside the uterus, producing prostaglandins, cytokines, and estrogen locally — even after the ovarian cycle has peaked. This hormonal and inflammatory spillover reaches the central nervous system.

Estrogen stabilizes serotonin receptors and modulates trigeminal nerve sensitivity. When estrogen falls in the late luteal phase, trigeminal pathways become hyperexcitable — the classical mechanism behind menstrual migraine (MacGregor, Cephalalgia 2020; PMID: 32056453). In people without endometriosis this drop is steep but brief. In endometriosis, perilesional estrogen synthesis continues past the systemic drop, creating an irregular hormonal signal that appears to amplify trigeminal sensitization.

A 2016 study of 1,060 women with laparoscopically confirmed endometriosis found that 56% reported migraines or severe headaches, compared with 30% of age-matched controls — nearly double the rate (Ferrero et al., Human Reproduction 2016; PMID: 26802111). Headache frequency correlated with disease stage and with self-reported pain severity, suggesting shared inflammatory pathways rather than coincidence.

Prostaglandin E2 (PGE2), overproduced in endometriotic lesions, crosses into systemic circulation before menstruation. PGE2 directly sensitizes meningeal nociceptors and promotes vasodilation — two steps that precede the pain phase of migraine (Bhatt et al., Cephalalgia 2014; PMID: 24336293). This explains why NSAIDs started 48 hours before expected menstruation can blunt — but rarely eliminate — headaches in endometriosis.

The Role of Iron Loss and Cyclical Anemia

Heavy menstrual bleeding (HMB) occurs in roughly 60% of people with endometriosis, and repeated monthly blood loss is a primary cause of iron deficiency in this population. Iron is required for hemoglobin synthesis, mitochondrial energy production, and dopamine biosynthesis — three pathways directly involved in headache pathophysiology.

Low serum ferritin (even when hemoglobin is still technically "normal") correlates with increased headache frequency. A cross-sectional study of 200 women with chronic migraine found that ferritin levels below 50 ng/mL were associated with significantly higher monthly headache days compared to those with ferritin above 100 ng/mL (Dominguez et al., Headache 2021; PMID: 34101188). Iron repletion in iron-deficient migraineurs reduced headache frequency by roughly 30% over 12 weeks in a small interventional trial.

Understanding iron bisglycinate vs ferrous sulfate matters here because the form of iron supplement significantly affects both absorption and gastrointestinal tolerability. Iron bisglycinate (ferrous bisglycinate) achieves comparable or superior serum ferritin increases at doses that produce far fewer GI side effects than ferrous sulfate — a relevant consideration when someone is already dealing with endometriosis-related bowel symptoms.

The timing of iron supplementation also deserves attention. Research suggests that taking iron before bed can improve absorption in some individuals because gastric acidity is higher and competing dietary calcium is absent during overnight fasting — though this strategy is most relevant for those with confirmed low ferritin, not as a universal recommendation.

How Estrogen Withdrawal Triggers the Headache Cascade

The estrogen-withdrawal hypothesis for menstrual migraine is well-supported. Estrogen primes the trigeminal vascular system: during the mid-luteal phase when estrogen is high, pain thresholds are elevated. When estrogen drops in the 48 hours before menstruation, the trigeminal nucleus caudalis becomes sensitized, calcitonin gene-related peptide (CGRP) release increases, and meningeal blood vessels dilate.

In endometriosis, this cascade is worsened by three factors:

1. Ectopic estrogen synthesis — lesions express aromatase and produce estrogen locally, creating discordant signals between systemic and local estrogen levels.
2. Elevated prostaglandins — PGE2 and PGF2α are pro-inflammatory and vasodilatory, amplifying the trigeminal response.
3. Dysregulated HPA axis — chronic pelvic pain activates the stress response, raising cortisol and lowering serotonin, both of which lower the headache threshold.

This combination means that even women whose systemic estrogen does not fall dramatically may still experience premenstrual headaches if ectopic lesions are active — which is one reason hormonal suppression therapies do not reliably eliminate headaches in everyone with endometriosis.

If you are also navigating mood changes alongside head pain, low mood is common in endometriosis and shares some of the same serotonergic and inflammatory roots. Similarly, brain fog in endometriosis may reflect the same neuroinflammatory burden that makes headaches more frequent and more severe.

Magnesium, Riboflavin, and Evidence-Based Nutritional Strategies

Before examining what works, it helps to understand the nutrient depletions that worsen premenstrual headaches in endometriosis:

Magnesium has the most robust evidence. A randomized controlled trial of 81 migraine patients found that 600 mg magnesium dicitrate per day for 12 weeks reduced attack frequency by 41.6% versus 15.8% in placebo (Peikert et al., Cephalalgia 1996; PMID: 8899295). The American Headache Society lists magnesium as a Level A preventive supplement. Menstrual migraine specifically responds to magnesium because the late-luteal drop in magnesium parallels the drop in estrogen — and low magnesium directly increases trigeminal excitability.

Omega-3 fatty acids reduce the availability of arachidonic acid for prostaglandin synthesis. Because prostaglandins are a central driver of both pelvic pain and headache in endometriosis, EPA/DHA supplementation addresses two problems simultaneously. A 2018 meta-analysis of seven trials found that omega-3 supplementation significantly reduced menstrual pain intensity (Niazi & Morales, Complementary Therapies in Medicine 2018), which supports its plausibility for prostaglandin-driven headaches as well.

What This Means for Your Formula

Not every supplement helps every person. But in endometriosis-associated premenstrual headaches, the combination of hormonal instability, prostaglandin excess, and frequent iron deficiency creates clear, addressable nutrient gaps.

Ones reviews your lab results — including ferritin, CBC, and inflammatory markers — alongside wearable data to identify which of these pathways is most active for you. Based on those findings, a custom capsule formula might include:

• Magnesium Glycinate — Ones formulas include a Magnesium Complex calibrated to clinical evidence. Magnesium glycinate is the form with the best absorption and lowest laxative risk, relevant for endometriosis patients with bowel symptoms. The AHS-supported preventive dose is 400–600 mg elemental magnesium daily.
• Omega-3 EPA/DHA — Included at doses that meaningfully shift the ratio of anti-inflammatory to pro-inflammatory eicosanoids. The target in clinical trials for menstrual pain is typically 1,800–2,000 mg combined EPA+DHA daily.
• CoQ10/Ubiquinol at 200 mg — Mitochondrial dysfunction has been proposed as a shared mechanism in both endometriosis lesion metabolism and migraine pathophysiology. Ones uses the ubiquinol form at 200 mg, the dose associated with measurable reduction in migraine attack frequency in deficient patients.

If your ferritin is confirmed low, iron as bisglycinate would be the preferred form — gentler on the gut while still repleating stores. Ones does not guess at your iron status; it requires actual lab data before including iron support in a formula.

Distinguishing Endometriosis Headaches from Other Cyclical Headaches

Not all premenstrual headaches in people with endometriosis are caused by the disease itself. It helps to know the differential:

• PCOS-associated headaches often relate to insulin resistance and androgens rather than estrogen withdrawal. Headaches before your period in PCOS have a distinct hormonal profile.
• Perimenopause-related headaches involve greater estrogen fluctuation amplitude. Cyclical headaches in perimenopause may worsen as ovarian reserve declines, even in people who previously had mild endometriosis.
• PMDD is characterized by severe luteal phase mood symptoms alongside physical symptoms including headache — headaches before your period in PMDD are driven more by serotonergic sensitivity than by prostaglandins.

If you have endometriosis and your headaches changed in character, frequency, or severity, tracking them alongside your cycle length and flow volume is clinically useful data. Wearable HRV and sleep data can also detect the autonomic shifts that precede migraine in some people.

When to Talk to a Healthcare Provider

Premenstrual headaches in endometriosis warrant medical evaluation when:

• They are disabling (vomiting, inability to work or care for children)
• They include neurological symptoms: visual aura, speech changes, unilateral weakness
• Frequency is increasing cycle-over-cycle
• Over-the-counter analgesics are needed more than 10 days per month (medication-overuse threshold)
• They are accompanied by very heavy bleeding (soaking a pad or tampon per hour for multiple hours)

A healthcare provider can assess whether hormonal management, CGRP-targeted therapies, or iron infusion is appropriate alongside nutritional strategies.

Key Takeaways

• Premenstrual headaches are nearly twice as common in endometriosis as in the general population, driven by prostaglandin excess, ectopic estrogen synthesis, and systemic inflammation.
• The late-luteal estrogen drop triggers trigeminal sensitization — a mechanism amplified in endometriosis by ongoing lesional activity.
• Iron deficiency from heavy menstrual bleeding independently increases headache frequency; ferritin below 50 ng/mL is a modifiable risk factor worth testing.
• Magnesium (400–600 mg/day) has Level A evidence for migraine prevention and is particularly relevant in the luteal phase when magnesium levels dip alongside estrogen.
• Omega-3 EPA/DHA reduces prostaglandin synthesis and addresses both pelvic pain and headache in endometriosis through the same anti-inflammatory pathway.
• Personalized supplementation — based on actual lab results rather than guesswork — is more likely to address the specific nutrient gaps driving your headaches than a generic multivitamin approach.